PDL BioPharma, Inc. (NASDAQ: PDLI) announced that it intends to offer, subject to market and other conditions, $250 million aggregate principal amount of new convertible senior notes due February 1, 2018 (notes) under the Company’s shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) on June 21, 2013. PDL BioPharma Inc. (NASDAQ:PDLI) stock opened at $8.29 in last session, and closed at $7.46, while the day range of PDLI stock is $7.38 – $8.35. The stock showed a negative weekly performance of -16.37%.
Cell Therapeutics Inc (NASDAQ:CTIC) announced that Karen Ignagni has been appointed a director of CTI, effective immediately. Cell Therapeutics Inc (NASDAQ:CTIC) stock opened at $3.04, in last session and closed at $2.84, by losing -7.19%. The 52 week range of CTIC is $0.97 – $4.25. Company’s market capitalization is $415.17million.
Agenus Inc. (NASDAQ:AGEN) announced that it has commenced an underwritten public offering of shares of its common stock. Agenus Inc (NASDAQ:AGEN) stock decreased -6.21% and finished the last session at $2.72. The EPS of the stock remained -1.23. Company’s market capitalization is $96.49million.
InterMune Inc (NASDAQ:ITMN) is suffering from a possible trial data leak from a competitor’s idiopathic pulmonary fibrosis drug, which successfully passed its phase 3 trials, and put up solid data. InterMune Inc (NASDAQ:ITMN) stock opened the session at $12.20, and closed the session at $11.63. The 52 week range of the ITMN stock remained $8.21 – $18.39 and the day range was $10.95 – $12.30.